Q2 2026 13F · SEC CIK 2109256
Balance Capital Partners L.P.
Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $139.3M
- Reported positions
- 10
- Holdings vs S&P 500, 3 yrs
- —
- Assets under management
- $195.7M
Balance Capital Partners L.P. is a hedge fund that reported 10 positions worth $139.3M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Perimeter Solutions Inc (PRM, 70.0%), Spdr Series Trust (XBI, 7.3%), Resolute Hldgs Mgmt Inc (RHLD, 6.7%).
Balance Capital Partners L.P. holdings all 10 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| PRMPerimeter Solutions Inc | 70.0% | +0.0% | $97.5M |
| XBISpdr Series Trust | 7.3% | — | $10.1M |
| RHLDResolute Hldgs Mgmt Inc | 6.7% | +0.0% | $9.3M |
| TSMTaiwan Semiconductor Manufac | 3.8% | — | $5.3M |
| BLTEBelite Bio Inc | 2.5% | +55.2% | $3.5M |
| CPNGCoupang Inc | 2.5% | — | $3.4M |
| SNSharkninja Inc | 2.2% | — | $3.1M |
| MRVLMarvell Technology Inc | 1.9% | — | $2.7M |
| TTMITtm Technologies Inc | 1.7% | — | $2.4M |
| DNAGinkgo Bioworks Holdings Inc Cl A | 1.4% | — | $2.0M |
What Balance Capital Partners L.P. bought and sold in Q2 2026, against Q1 2026.
New positions
- XBI Spdr Series Trust7.3% of 13F
- TSM Taiwan Semiconductor Manufac3.8% of 13F
- CPNG Coupang Inc2.5% of 13F
- SN Sharkninja Inc2.2% of 13F
- MRVL Marvell Technology Inc1.9% of 13F
- TTMI Ttm Technologies Inc1.7% of 13F
- DNA Ginkgo Bioworks Holdings Inc Cl A1.4% of 13F
Added to
- BLTE Belite Bio Inc+55.2% shares
Reduced
No position shrank by more than 5%.
Sold out
- STVN Stevanato Group S P Awas 5.2%
- GEV Ge Vernova Incwas 2.7%
- CLBT Cellebrite Di Ltdwas 1.6%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- —
- 3 years
- —
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $139.3M | 10 |
| Q1 2026 | $87.9M | 6 |
Questions about Balance Capital Partners L.P.'s portfolio
What stocks does Balance Capital Partners L.P. own?
Balance Capital Partners L.P.'s latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 10 positions worth $139.3M. The largest are Perimeter Solutions Inc (PRM) at 70.0%, Spdr Series Trust (XBI) at 7.3%, Resolute Hldgs Mgmt Inc (RHLD) at 6.7%, Taiwan Semiconductor Manufac (TSM) at 3.8% and Belite Bio Inc (BLTE) at 2.5%.
What did Balance Capital Partners L.P. buy last quarter?
In Q2 2026, Balance Capital Partners L.P. added a new position in Spdr Series Trust (XBI), a new position in Taiwan Semiconductor Manufac (TSM), a new position in Coupang Inc (CPNG), a new position in Sharkninja Inc (SN), a new position in Marvell Technology Inc (MRVL) and Belite Bio Inc (BLTE) (+55.2% shares), compared with its Q1 2026 filing.
What did Balance Capital Partners L.P. sell last quarter?
In Q2 2026, Balance Capital Partners L.P. sold all of Stevanato Group S P A (STVN), sold all of Ge Vernova Inc (GEV) and sold all of Cellebrite Di Ltd (CLBT), compared with its Q1 2026 filing.
When is Balance Capital Partners L.P.'s next 13F filing due?
13F filings are due 45 days after each quarter ends. Balance Capital Partners L.P.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Balance Capital Partners L.P. manage?
Balance Capital Partners L.P. reported $195.7M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $139.3M.